Graham J, Baker M, Macbeth F, Titshall V: Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ. 2008, 336: 610-612. 10.1136/bmj.39498.525706.AD.
Article
PubMed
PubMed Central
Google Scholar
Thickman D, Speers WC, Philpott PJ, Shapiro H: Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol. 1996, 156: 110-113. 10.1016/S0022-5347(01)65956-1.
Article
CAS
PubMed
Google Scholar
Moreira Leite KR, Camara-Lopes LH, Dall'oglio MF, Cury J, Antunes AA, Sanudo A: Upgrading the Gleason score in extended prostate biopsy: implications for treatment choice. Int J Radiat Oncol Biol Phys. 2009, 73: 353-356. 10.1016/j.ijrobp.2008.04.039.
Article
PubMed
Google Scholar
Muntener M, Epstein JI, Hernandez DJ, Gonzalgo ML, Mangold L, Humphreys E: Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy. Eur Urol. 2008, 53: 767-775. 10.1016/j.eururo.2007.11.016.
Article
PubMed
Google Scholar
Pinthus JH, Witkos M, Fleshner NE, Sweet J, Evans A, Jewett MA: Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol. 2006, 176: 979-984. 10.1016/j.juro.2006.04.102.
Article
PubMed
Google Scholar
Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL: Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?. J Urol. 2006, 176: 2453-2458. 10.1016/j.juro.2006.08.014.
Article
PubMed
Google Scholar
Grossfeld GD, Chang JJ, Broering JM, Li JP, Lubeck DP, Flanders SC: Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol. 2001, 165: 851-856. 10.1016/S0022-5347(05)66543-3.
Article
CAS
PubMed
Google Scholar
Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS: Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. Urology. 2008, 72: 177-182. 10.1016/j.urology.2007.10.022.
Article
PubMed
Google Scholar
Isariyawongse BK, Sun L, Banez LL, Robertson C, Polascik TJ, Maloney K: Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen. Urology. 2008, 72: 882-886. 10.1016/j.urology.2008.02.021.
Article
PubMed
Google Scholar
Antunes AA, Leite KR, Dall'oglio MF, Cury J, Srougi M: The effect of the number of biopsy cores on the concordance between prostate biopsy and prostatectomy Gleason score: a prostate volume-controlled study. Arch Pathol Lab Med. 2008, 132: 989-992.
PubMed
Google Scholar
D'Amico AV, Renshaw AA, Arsenault L, Schultz D, Richie JP: Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys. 1999, 45: 841-846. 10.1016/S0360-3016(99)00260-6.
Article
PubMed
Google Scholar
Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP: EAU guidelines on prostate cancer. Eur Urol. 2008, 53: 68-80. 10.1016/j.eururo.2007.09.002.
Article
PubMed
Google Scholar
Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V: EAU guidelines on prostate cancer. part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011, 59: 61-71. 10.1016/j.eururo.2010.10.039.
Article
PubMed
Google Scholar
Bouchardy C: Switzerland, Geneva. Cancer Incidence in Five Continents Vol. IX. Edited by: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M. 2007, Lyon: International Agency for Research on Cancer, 369-370.
Google Scholar
Kramer MS, Feinstein AR: Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther. 1981, 29: 111-123. 10.1038/clpt.1981.18.
Article
CAS
PubMed
Google Scholar
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33: 159-174. 10.2307/2529310.
Article
CAS
PubMed
Google Scholar
Kvale R, Moller B, Wahlqvist R, Fossa SD, Berner A, Busch C: Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int. 2009, 103: 1647-1654. 10.1111/j.1464-410X.2008.08255.x.
Article
PubMed
Google Scholar
Zaytoun OM, Anil T, Moussa AS, Jianbo L, Fareed K, Jones JS: Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors. Urology. 2011, 77: 910-914. 10.1016/j.urology.2010.12.033.
Article
PubMed
Google Scholar
Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994, 151: 1283-1290.
CAS
PubMed
Google Scholar
Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT: The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol. 1994, 152: 1714-1720.
CAS
PubMed
Google Scholar
Cumming JA, Ritchie AW, Goodman CM, McIntyre MA, Chisholm GD: De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease. Br J Urol. 1990, 65: 271-274. 10.1111/j.1464-410X.1990.tb14725.x.
Article
CAS
PubMed
Google Scholar
Cheng L, Slezak J, Bergstralh EJ, Cheville JC, Sweat S, Zincke H: Dedifferentiation in the metastatic progression of prostate carcinoma. Cancer. 1999, 86: 657-663. 10.1002/(SICI)1097-0142(19990815)86:4<657::AID-CNCR15>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Epstein JI, Allsbrook WC, Amin MB, Egevad LL: Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol. 2006, 13: 57-59. 10.1097/01.pap.0000202017.78917.18.
Article
PubMed
Google Scholar
Burchardt M, Engers R, Muller M, Burchardt T, Willers R, Epstein JI: Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays. J Cancer Res Clin Oncol. 2008, 134: 1071-1078. 10.1007/s00432-008-0388-0.
Article
CAS
PubMed
Google Scholar
Epstein JI, Allsbrook WC, Amin MB, Egevad LL: The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005, 29: 1228-1242. 10.1097/01.pas.0000173646.99337.b1.
Article
PubMed
Google Scholar
Billis A, Guimaraes MS, Freitas LL, Meirelles L, Magna LA, Ferreira U: The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. J Urol. 2008, 180: 548-552. 10.1016/j.juro.2008.04.018.
Article
PubMed
Google Scholar
Helpap B, Egevad L: The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch. 2006, 449: 622-627. 10.1007/s00428-006-0310-6.
Article
PubMed
Google Scholar
Egevad L, Mazzucchelli R, Montironi R: Implications of the International Society of Urological Pathology modified Gleason grading system. Arch Pathol Lab Med. 2012, 136: 426-434. 10.5858/arpa.2011-0495-RA.
Article
PubMed
Google Scholar
van den Bergh RC, Roemeling S, Roobol MJ, Wolters T, Schroder FH, Bangma CH: Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer–a review. Eur Urol. 2008, 54: 505-516. 10.1016/j.eururo.2008.06.040.
Article
CAS
PubMed
Google Scholar